PEDs Drug Quiz 2

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/41

encourage image

There's no tags or description

Looks like no tags are added yet.

42 Terms

1
New cards

Drug classes used to treat apnea of prematurity

-Methylxanthines

2
New cards

Methylxanthine drugs

-Caffeine citrate

-Theophylline

3
New cards

Caffeine citrate brand name

Cafcit; FT Stay Awake [OTC]; Keep Alert [OTC]; Stay Awake Maximum Strength [OTC] [DSC]; Stay Awake [OTC]; Vivarin [OTC]

4
New cards

Which methylxanthine is preferred for apnea of prematurity?

Caffeine (lower risk of AE)

5
New cards

MOA of drug class

increase central respiratory drive by lowering the threshold of response to hypercapnia as well as enhancing contractility of the diaphragm.

6
New cards

Dosage forms of caffeine citrate

IV or oral solution

7
New cards

Dosing of caffeine

Initial loading dose: oral, IV: 20mg/kg followed 24 hours later by once-daily maintenance doses of 5-10mg/kg

8
New cards

When is caffeine discontinued?

-Usually continued until an infant is free of clinically significant apnea or bradycardia for 5-7 days without positive pressure respiratory support, or at 34 weeks postmenstrual age (PMA)

-In general, caffeine is typically discontinued at 33 to 35 weeks PMA if no apneic episodes have occurred for the last 5 to 7 days

9
New cards

MOA of caffeine citrate

Increases levels of 3'5' cyclic AMP by inhibiting phosphodiesterase; CNS stimulant which increases medullary respiratory center sensitivity to carbon dioxide, stimulates central inspiratory drive, and improves skeletal muscle contraction (diaphragmatic contractility); prevention of apnea may occur by competitive inhibition of adenosine

10
New cards

Caffeine AE (>10%)

-Epidermal thinning, skin rash, xeroderma

-Acidosis

-Gastritis, GI hemorrhage

-Disseminated intravascular coagulation, hemorrhage

-Sepsis

-Cerebral hemorrhage

-Retinopathy of prematurity

-Kidney failure

-Dyspnea, pulmonary edema

-Abnormal healing, feeding intolerance

11
New cards

DDI with caffeine citrate

Substrate/inhibitor/inducer of CYP1A2, CYP2CP

12
New cards

CI of caffeine citrate

-Hypersensitivity to caffeine or any component of formulation

-Avoid products containing: Sodium benzoate is not for use in neonates

13
New cards

Caffeine has a caution of developing:

necrotizing enterocolitis

14
New cards

Due to ____ therapeutic index, caffeine serum drug concentration monitoring is unnecessary

wide

15
New cards

Theophylline brand name

Elixophyllin, Theo-24

16
New cards

Theophylline dosage form

oral solution

17
New cards

Theophylline dosing

-Preterm neonates: Oral: Immediate-release oral solution:

-Loading dose: 5 to 6 mg/kg/dose (Ref).

-Maintenance: 2 to 6 mg/kg/day divided every 8 to 12 hours

18
New cards

Theophylline is also indicated for:

reversible airflow obstruction

19
New cards

MOA of theophylline

Theophylline has two distinct actions; smooth muscle relaxation (ie, bronchodilation) and suppression of the response of the airways to stimuli (ie, non-bronchodilator prophylactic effects). Bronchodilation is mediated by inhibition of two isoenzymes, phosphodiesterase (PDE III and, to a lesser extent, PDE IV) while non-bronchodilation effects are mediated through other molecular mechanisms. Theophylline increases the force of contraction of diaphragmatic muscles through enhancement of calcium uptake through adenosine-mediated channels.

20
New cards

Theophylline AE (>10%)

-Frequency not defined:

-Hypercholesterolemia (including increased HDL cholesterol), increased cortisol (urinary free cortisol excretion), increased free fatty acids

-N/V

-HA, insomnia

Postmarketing:

-Cardiac arrhythmia, palpitations, sinus tachycardia

-Pruritus, skin rash, urticaria

-Hypercalcemia, hyperglycemia, hyperuricemia, hypokalemia (Koh 2002), lactic acidosis

-Abdominal pain, diarrhea, gastric irritation, gastroesophageal reflux disease

-Diuresis, urinary retention

-Anaphylaxis, nonimmune anaphylaxis

-Agitation, anxiety, irritability, restlessness, seizure, tremor

21
New cards

DDI of theophylline

Substrate of CYP1A2 (Major), CYP2E1 (Minor), CYP3A4 (Minor)

22
New cards

CI of theophylline

Hypersensitivity to theophylline or any component of the formulation

23
New cards

Caution/warning of theophylline

Theophylline toxicity: Severe and potentially fatal theophylline toxicity may occur if reduced theophylline clearance occurs.

s/sx: N, persistent, repetitive vomiting

24
New cards

Monitoring of theophylline

serum theophylline concentrations are required

25
New cards

What drug class is used to treat patent ductus arteriosus?

Cyclooxygenase inhibitors (NSAIDs)

26
New cards

Cyclooxygenase inhibitors used in patent ductus arteriosus

-Indomethacin

-Ibuprofen

27
New cards

Indomethacin brand name

Indocin

28
New cards

Indomethacin MOA

Reversibly inhibits cyclooxygenase-1 and 2 (COX-1 and 2) enzymes, which results in decreased formation of prostaglandin precursors; has antipyretic, analgesic, and anti-inflammatory properties

29
New cards

Indomethacin BW

-Serious CV thrombotic events

-Serious GI bleeding, ulceration, and perforation

30
New cards

CI of indomethacin

-Hypersensitivity

-Use in setting of CABG surgery

-Hx of asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAID agents

-Pts with Hx of proctitis or recent rectal bleeding

-Necrotizing enterocolitis (proven or suspected)

-significant kidney impairment; active bleeding (including intracranial hemorrhage and gastrointestinal bleeding)

-Thrombocytopenia

-coagulation defects

-untreated infection (proven or suspected)

-congenital heart disease where patency of the ductus arteriosus is necessary for adequate pulmonary or systemic blood flow (eg, pulmonary atresia, severe tetralogy of Fallot, severe coarctation of the aorta)

31
New cards

Indomethacin dosage form

IV

32
New cards

Indomethacin dosing

Standard dosing:

-Preterm neonates: IV 0.2mg/kg/dose every 12 hours for 3 doses

PNA-based dosing:

Preterm neonates (Ref):

-Initial: IV: 0.2 mg/kg/dose, followed by 2 doses depending on PNA:

-PNA at time of first dose

33
New cards

Indomethacin monitoring

urine output prior to initiation and throughout course of therapy

34
New cards

Storage of indomethacin

IV: Store at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F).

-Protect from light.

-Store vials in original carton until contents used.

35
New cards

AE of indomethacin

-Necrotizing enterocolitis

-Oligouria

-Vomiting

-Postoperative hemorrhage

-Headache

36
New cards

Ibuprofen brand name

Motrin, Advil

37
New cards

Ibuprofen MOA

Reversibly inhibits cyclooxygenase-1 and 2 (COX-1 and 2) enzymes, which results in decreased formation of prostaglandin precursors; has antipyretic, analgesic, and anti-inflammatory properties

38
New cards

Ibuprofen BW

-Serious CV thrombotic events

-Serious GI bleeding, ulceration, and perforation

39
New cards

Ibuprofen CI

During the perioperative setting or coronary artery bypass graft (CABG) surgery

40
New cards

Ibuprofen dosing

Standard-dose therapy:

-GA

41
New cards

What body weight do you use to do ibuprofen?

birth body weight

42
New cards

Monitoring for ibuprofen

urine output